ATROPHY, GEOGRAPHIC

Clinical trials for ATROPHY, GEOGRAPHIC explained in plain language.

Never miss a new study

Get alerted when new ATROPHY, GEOGRAPHIC trials appear

Sign up with your email to follow new studies for ATROPHY, GEOGRAPHIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New pill aims to slow blinding eye disease

Disease control Completed

This study tested whether a daily capsule called ALK-001 could slow the progression of geographic atrophy, a severe form of age-related macular degeneration that causes permanent vision loss. About 300 people with this condition were randomly assigned to receive either the study …

Matched conditions: ATROPHY, GEOGRAPHIC

Phase: PHASE2, PHASE3 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

ATROPHY, GEOGRAPHIC

Get alerted when new ATROPHY, GEOGRAPHIC trials appear

New pill aims to slow blinding eye disease